Estimated price of larotinib/larlotinib in medical insurance in 2025

Larotrectinib is a targeted drug targeting specific gene mutations and is mainly used to treat tumors with NTRK gene fusions. The introduction of this drug provides a new treatment option for some patients with advanced cancer. With the launch of larotrectinib in China and its inclusion in medical insurance, patient accessibility has been significantly improved. However, the price of larotrectinib remains a key concern for patients and the medical system.

In the domestic market, the price of larotrectinib’s original drug is relatively high.A capsule preparation of 100mg*56 capsules costs about 20,000 yuan, while an oral solution preparation of 50ml:1.0g*2 bottles is more expensive. Although the drug's efficacy is widely recognized, financial burden remains an important consideration for many patients. With the support of medical insurance policies, patients can obtain certain reimbursements in actual payments, which relieves their financial pressure to a certain extent.

According to the current medical insurance policy, the reimbursement ratio of larotrectinib will vary by region, so patients are recommended to consult the local hospital pharmacy before purchasing to obtain the latest reimbursement information. This process is very important for patients because reimbursement standards and policies for drugs may vary significantly in different regions. Moreover, updates and adjustments to the medical insurance catalog may also affect the availability and price of drugs. Therefore, it is a necessary task for patients and their families to continue to pay attention to the dynamic changes in medical insurance policies.

In addition, patients may also consider generic drug options in overseas markets when choosing larotrectinib. The price of these generic drugs is usually significantly lower than that of the original drugs. For example, the price of the Laos version of the same specifications of generic drugs is only a few hundred yuan to more than a thousand yuan. Although the production process of generic drugs may be different from that of original drugs, from the perspective of drug ingredients, the two are basically the same, which is a positive guarantee for the efficacy and safety of the drug.

Reference materials:https://www.vitrakvi.com/